4//SEC Filing
Buck Kristen K 4
Accession 0001879231-26-000003
CIK 0000320017other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:07 PM ET
Size
13.6 KB
Accession
0001879231-26-000003
Insider Transaction Report
Form 4
Buck Kristen K
EVP, R&D and CMO
Transactions
- Award
Common Stock
[F1][F2]2026-01-09+25,000→ 104,794 total - Tax Payment
Common Stock
[F3][F2]2026-01-09$1.97/sh−2,982$5,875→ 101,812 total - Tax Payment
Common Stock
[F3][F2]2026-01-09$1.97/sh−2,982$5,875→ 98,830 total - Tax Payment
Common Stock
[F3][F2]2026-01-09$1.97/sh−3,221$6,345→ 95,609 total - Tax Payment
Common Stock
[F3][F2]2026-01-09$1.97/sh−2,147$4,230→ 93,462 total - Award
Stock Option (Right to Buy)
[F4]2026-01-09+13,000→ 13,000 totalExercise: $1.97From: 2026-01-09Exp: 2036-01-09→ Common Stock (13,000 underlying)
Footnotes (4)
- [F1]Represents 25,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
- [F2]Includes 38,000 unvested restricted stock.
- [F3]Shares withheld as payment of a tax liability on vesting of restricted stock.
- [F4]One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third anniversaries of the grant date.
Signature
James Nisco, Attorney-in-Fact for Kristen K. Buck|2026-01-13
Documents
Issuer
LISATA THERAPEUTICS, INC.
CIK 0000320017
Entity typeother
Related Parties
1- filerCIK 0001879231
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 4:07 PM ET
- Size
- 13.6 KB